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Abstract
Introduction. Exposure to Asian sand dust (ASD) is associated with enhanced pulmonary morbidity and mor-
tality, and the reporting of such cases has rapidly increased in East Asia since 2000. The purpose of the study 
was to assess chronic lung toxicity induced by ASD.
Material and methods. A total of 174 ICR mice were randomly divided into 5 control and 17 exposure groups. 
Suspensions of low dose (0.2, 0.4 mg) and high dose (3.0 mg) of ASD particles in saline were intratracheally 
instilled into ICR mice, followed by sacrifice at 24 hours, 1 week, and 1, 2, 3 and 4 months after instillation. 
Paraffin sections of lung tissues were stained with hematoxylin and eosin and by immunohistochemistry to detect 
a-smooth muscle actin, collagen III, matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinases-1 
(TIMP-1), CD3, CD20, immunoglobulin G, interleukin-1b and inducible nitric oxide synthase.
Results. A lung histological examination revealed similar patterns in the lesions of the groups treated with high 
(3.0 mg) or low dose (0.4 mg) of ASD. Acute inflammation was observed 24 h after treatment and subsided after 
1 week; persistent granulomatous changes were observed at 2 months, focal lymphocytic infiltration at 3 months, 
and granuloma formation at 4 months. An increase in the size of granulomatous lesions was observed over time 
and was accompanied by collagen deposition in the lesions. The cytoplasm of macrophages in inflammatory 
lesions showed positive immunolabeling for MMP-9 at 24 h, 1 and 2 months after instillation of 3.0 mg of ASD. 
Positive immunolabeling for TIMP-1 was demonstrated in the cytoplasm of macrophages at 2 and 4 months 
after instillation of 3.0 mg of ASD. These findings suggest association between the expression of MMP-9 and 
TIMP-1 with the development of lung granulomatous lesions. 
Conclusions. These findings suggest that collagen deposition resulting from the altered regulation of extracel-
lular matrix is associated with granuloma formation in the lungs of mice treated with ASD. (Folia Histochemica 
et Cytobiologica 2015, Vol. 53, No. 4, 294–306)
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Introduction
Asian sand dust (ASD; known as Kosa aerosol) origi-
nating from the arid deserts of Mongolia and China 
causes severe air pollution annually in the Asia-Pacific 
area, including China, Korea, and Japan 1 [1]. Epide-
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miological studies of ASD in humans have shown that 
exposure to ambient ASD particles is associated with 
an increase in pulmonary [2–6] and cardiovascular 
problems [2, 3, 7, 8], and increased mortality in Korea 
[9–12] and Taiwan [13]. The frequency and scale of 
dust events giving rise to ASD aerosols have increased 
rapidly in East Asia since 2000 [14]. Because of recent 
environmental changes such as desertification and 
global warming, human and animals are at increased 
risk of frequent exposure to ASD and the resultant ad-
verse health effects of ASD on the respiratory system.
A previous study [15] reported that the major 
mineralogical component of ASD is silica (SiO2). Oc-
cupational exposure to crystalline silica is associated 
with silicosis, lung cancer, pulmonary tuberculosis, 
and chronic obstructive pulmonary disease [16]. In 
addition, patients with silicosis often develop autoim-
mune diseases [17, 18]. It has been reported that ex-
perimental chronic exposure to crystalline silica caused 
granuloma formation [19–23] and/or fibrosis [24] in 
rats. In addition, granulomatous inflammation, which 
is characterized by the accumulation of epithelioid 
macrophages containing crystalline silica particles in 
the tracheobronchial lymph nodes, has been reported 
in rats exposed to crystalline silica [20, 25, 26].
Previous studies on pulmonary toxicity caused by in-
tratracheally instilled high doses of ASD demonstrated 
that the mineralogical components of ASD particles, 
free from chemical and biological pollutants, caused 
acute inflammatory changes in lung tissues [27–29]. 
Indeed, these chronic changes were similar to those 
observed in the silica exposure study: focal infiltration 
of lymphocytes with an accumulation of epithelioid 
macrophages and granuloma formation in the lung, and 
aggregation of macrophages containing particles in the 
tracheobronchial lymph nodes, 2 and 3 months after 
instillation. These findings suggested that precautions 
should be taken to minimize exposure to ASD. Addi-
tionally, more experimental studies using the inhalation 
method with lower doses of ASD to mimic the natural 
low-level exposure occurring during the Kosa event 
season should be conducted in the future.
The purpose of the current study was to describe 
the chronic lung toxicity induced by intratracheally 
instilled low doses of ASD in mice and to elucidate 
the pathomorphogenesis of granuloma formation. 
Material and methods
Animals. A total of 174 male ICR mice (5 or 6 weeks old) 
were obtained from CLEA JAPAN Inc. (Tokyo, Japan). 
Animals were fed a CE-2 diet purchased from CLEA 
JAPAN, and water was provided ad libitum. The mouse 
cages were housed at a temperature of about 25°C with 
55–70% humidity. All animal experiments were performed 
according to the Tottori University guidelines for animal 
welfare (http://www.tottori-u.ac.jp/kouhou/kisokusyuu/rei-
ki_honbun/u0950581001.html). Body weight changes were 
recorded weekly to assess general health.
Preparation of particle samples. CJ-2 particles, which are 
simulated ASD particles were used in this study. The CJ-2 
particles were obtained from General Science Corporation 
(Tokyo, Japan). The particles were collected from the 
surface soil in the southwest part of the Tengger desert in 
north-central China where dust storms occur frequently [15]. 
The CJ-2 particles contain 28.0% Si, 5.9% Al, 5.3% Ca, 
3.0% Fe, 1.7% K, and 1.6% Mg, and the mean diameter of 
the particles was approximately 0.03 mm ± 0.01 mm, ac-
cording to the manufacturer’s data sheet. The CJ-2 particles 
were hot-air sterilized at 300°C for 1 hour to remove toxic 
substances (microbiological substances as well as chemicals 
including nitrogen oxide and sulfur oxide) adhering to ASD. 
The sterilization temperature was determined in accordance 
with previous studies [27]. It has been reported that neither 
the chemical composition nor the shape of mineral particles 
changed even when heated to 700°C [30].
Preparation of ASD suspensions. The sterilized particles 
were suspended in 0.05 mL of sterilized saline solution for 
instillation. The suspensions were deflocculated via ultrason-
ic disintegration for 3 minutes. Three doses (low doses: 0.2 
and 0.4 mg; high dose: 3.0 mg) of the particles were chosen 
to determine dose effects on lung toxicity in mice. The max-
imum deposition of particles in the lung of a single mouse 
was calculated using tidal volume and breathing rate [27]. 
The maximum weekly deposition of suspended particulate 
matter (0.1 mg/m3), as measured by the Japanese national air 
quality standard, was approximately 0.03 mg. The instillation 
doses (0.2, 0.4 and 3.0 mg) in the present study represent 
6.6, 13.2 and 99 times that amount, respectively [28]. Control 
mice received 0.05 mL of a saline solution.
Study protocol. A total of 174 mice were randomly divided 
into 5 control and 17 exposure groups (Table 1). The mice 
were anesthetized by an intraperitoneal injection of sodium 
pentobarbital (5 mg/100 g body weight). The suspensions 
were agitated immediately before intratracheal instillation, 
and 0.05 mL of the suspension was instilled with an intratra-
cheal cannula in each mouse. Each intratracheal instillation 
procedure took 3 seconds.
The animals in each group were euthanized by exsan-
guination under deep anesthesia induced by intraperitoneal 
injection of sodium pentobarbital at 24 hours, 1 week, and 
1, 2, 3 and 4 months after instillation.
Pathological examination. Four mice from each control 
group and five to ten mice from each particle-treated group 
were used for pathological examination (Table 1). On dis-
section, the trachea was immediately exposed and 0.5 mL 
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of 10% neutral-buffered formalin was instilled gently with 
the use of syringe via the tracheal cannula at low pressure; 
formalin injection was carried out within 15 min after death. 
Whole lungs were removed and fixed by immersion in 10% 
neutral-buffered formalin for 1 day. Then, the lung lobes 
were separated, and transverse sections from each lobe 
were made. These transverse sections and tracheobronchial 
lymph nodes were placed into embedding cassettes and 
fixed by immersion in 10% neutral-buffered formalin for 
3 days. Formalin-fixed tissues of lungs and tracheobronchial 
lymph nodes were routinely processed and embedded in 
paraffin for histopathological and immunohistochemical 
examination. Sections approximately 3-μm thick were cut 
and stained with hematoxylin and eosin (H & E). Pathologi-
cal evaluations were performed by 2 pathologists. The area 
of each granuloma was measured by using the polygon area 
measurement function of a microscope digital camera DP21 
(Olympus, Tokyo, Japan). The number of granulomas in the 
lung of each mouse was determined.
Immunohistochemistry: polymer method. Paraffin-embed-
ded sections of the lungs of mice treated with saline alone 
or with 3.0 mg of ASD particles were used for immunohis-
tochemical detection of a-smooth muscle actin (a-SMA), 
collagen III, matrix metalloproteinase-9 (MMP-9), tissue 
inhibitor of metalloproteinases-1 (TIMP-1), CD3 (T lym-
phocyte marker), CD20 (B lymphocyte marker), immuno-
globulin G, interleukin-1b (IL-1b) and inducible nitric oxide 
synthase (iNOS). For antigen retrieval, the sections were 
placed in citrate buffer solution (pH 5.4) and microwaved for 
20 minutes. Endogenous peroxidase activity was quenched 
with 3% H2O2 for 30 minutes at room temperature. The 
slides were then blocked with 10% normal goat serum for 
one hour at room temperature. Thereafter, the sections were 
incubated in primary antibodies overnight at 4°C (anti-a-
SMA, Dako, Glostrup, Denmark, 1:80 dilution; anti-collagen 
III, Cosmo Bio Co. Ltd, Tokyo, Japan, 1:20,000 dilution; an-
ti-MMP-9, Bioss, Boston, USA, 1:200 dilution; anti-TIMP-1, 
Bioss, 1:100 dilution; anti-CD3, Dako, Glostrup, Denmark, 
1:400 dilution; anti-CD20, Thermo Fisher Scientific, CA, 
USA, 1:500 dilution; anti-mouse immunoglobulins, Dako, 
1:300 dilution; anti-IL-1b, Santa Cruz Biotechnology, CA, 
USA, 1:50 dilution; and anti-iNOS, Abcam, Cambridge, 
UK, 1:100 dilution). The primary antibodies were replaced 
with phosphate-buffered saline (PBS) in negative controls. 
After incubation with primary antibodies, the sections 
were placed in a solution containing a peroxidase-labeled 
polymer conjugated to secondary anti-mouse and -rabbit 
antibodies (EnVision + kit/HRP, Dako) for 30 min at RT 
temperature. The positive reactions resulted in brown stain-
ing with 3,3’-diaminobenzidine tetrahydrochloride (DAB, 
Wako, Osaka, Japan) as a chromogen, and the sections were 
counterstained with hematoxylin.
Statistical analysis. All data were expressed as the mean 
± standard deviation. Statistical analysis of the histopatho-
logical changes was performed using a Student’s t-test 
for two-group comparisons. For all comparisons, p values 
less than 5% (p < 0.05) were considered statistically 
significant.
Results
Gross findings of the lungs
At 3 and 4 months after instillation of 3.0 mg of ASD 
particles, the surface of the lungs was rough. In addi-
tion, multiple tiny whitish foci were observed in the 
parenchyma and surface of the lung. No significant 
changes were observed in the other treated groups. 
Histopathology of the lungs
Histological sections from control animals instilled 
with saline showed normal bronchiolar and alveolar 
architectures at all times examined. In histological 
sections from animals instilled with ASD parti-
cles, the particles were observed in the lungs at all 
times examined in all treated groups. The number 
of coarse particles detected at low magnification 
(×4) in the lung was consistent throughout the 
different time points in each treated group. Fine 
particles were also observed throughout the lungs 
in each treated group. Furthermore, the multifocal 
Table 1. Number of animals exposed to Asian sand dust particles and examined after time indicated
Groups Post-exposure time
24 hours 1 week 1 month 2 months 3 months 4 months
Control (saline) 4 4 4 4 4 NE
ASD 0.2 mg 10 10 10 10 8 NE
ASD 0.4 mg 9 10 10 10 8 11
ASD 3.0 mg 5 7 7 10 9 10
Total 28 31 31 34 29 21
Animals were treated as described in Material and methods. ASD — Asian sand dust; NE — not examined
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accumulation of particles, predominantly around 
the bronchioles, was observed at all times examined 
after treatment (Supplementary Figure 1). Inflam-
matory changes were observed around the particles; 
the intensity and frequency of the inflammation tend-
ed to increase with the amount of particles instilled 
(Supplementary Figure 1). There were no signs of 
infection in the lungs of any mice used in this study.
At 24 hours after instillation, the thickening of 
the alveolar wall accompanied by acute inflammatory 
changes, such as the infiltration of neutrophils and 
macrophages into the alveoli and bronchoalveolar 
junction, was observed in all treated groups (Supple-
mentary Figure 1A, B). 
At 1 week after instillation, the size of inflamma-
tory foci was similar to that observed in lungs taken at 
24 hours after instillation (Supplementary Figure 1C, D). 
The inflammatory foci were primarily composed of 
spindle-shaped to elongated cells, macrophages and 
a small number of neutrophils in all treated groups. 
Inflammatory foci containing a small number of mac-
rophages were also observed in all treated groups.
At 1 month after instillation, the size of inflamma-
tory foci observed in the lungs seemed to be smaller 
than those at 1 week after instillation (Supplementary 
Figure 1E, F). Inflammatory foci were composed of 
macrophages and occasional multinucleated giant cells. 
In addition to the inflammatory responses ob-
served in the lungs at 1 month after instillation, 
lung changes were reported in 60% of mice treated 
with 3.0 mg of ASD, at 2 months after instillation. 
These included the infiltration of lymphocytes and 
foamy macrophages around the blood vessels and 
bronchioli. Small granulomas, which were nodular 
foci of tightly clustered epithelioid macrophages and 
occasional multinucleated giant cells, were observed 
in the lungs of 10% of mice treated with 0.4 mg and 
60% of those treated with 3.0 mg of ASD, at 2 months 
after instillation (Supplementary Figure 1H, Table 2). 
Focal aggregations of macrophages containing fine 
particles without large particles were noted in the 
lungs of all treated groups of mice sacrificed at 2 to 
4 months after instillation.
At 3 months after instillation of ASD, granu-
lomatous lesions of various sizes and the infiltration 
of lymphocytes were observed in the 3.0 mg treated 
group. The number and size of granulomatous lesions 
increased over time from 2 to 3 months after instilla-
tion (Table 2); granuloma formation was observed in 
89% of mice treated with 3.0 mg of ASD. The granulo-
mas were composed of epithelioid cells, macrophages, 
multinucleated giant cells, neutrophils and large ASD 
particles (Supplementary Figure 1J). Lymphocytic 
infiltration was observed in 12.5% of mice treated 
with 0.4 mg of particles at 3 months after instillation 
(Supplementary Figure 1I, Supplementary Figure 2A, 
C, D, Table 2). Focal accumulation of large foamy 
macrophages (Supplementary Figure 2B), necrotic 
cells with scattered fine particles (Supplementary 
Figure 2A), neutrophils and epithelioid macrophages 
were occasionally observed; these findings were sim-
ilar to those reported at 2 months after instillation in 
the group treated with 3.0 mg of ASD (Supplementary 
Figure 1H). In addition, scattered plasma cells con-
taining Russell bodies (mott cells) [31] were observed 
around bronchioles at 3 months after instillation in 
the group treated with 3.0 mg of ASD.
At 4 months after instillation in the 3.0 mg treated 
group, the size of the granulomatous lesions were 
larger than those observed at 3 months, although 
the number of granuloma per mouse was almost the 
same (Table 2). Spindle-shaped cells appeared in 
the granulomatous lesions again and the volume of 
the interstitium of granulomatous lesions increased 
(Supplementary Figure 3A). Granuloma formation 
was observed in 45% of mice treated with 0.4 mg 
Table 2. Results of the quantitative analysis of the histopathological changes in the lungs of mice at 2, 3 and 4 months 
after Asian sand dust (ASD) instillation
Groups ASD dose Lymphocytic  
infiltration (%)1
Infiltration of 
mott cells (%)2
Granuloma  
formation (%)3
The number of  
granulomatous lesions4
The area of each  
granuloma (µm2)5
2 months
0.4 mg 0 0 10 0.1 ± 0.32 3.68 ± 2.31
3.0 mg 60 10 60 3.87 ± 3.74 1.36 ± 0.35
3 months
0.4 mg 12.5 0 0 0 –
3.0 mg 10 78 89 15.9 ± 11.9 2.23 ± 1.57
4 months
0.4 mg 18 18 45 7.09 ± 5.74 1.61 ± 0.77
3.0 mg 40 60 100 14 ± 8.10 4.11 ± 2.86
Percentage of animal which showed 1lymphocytic infiltration, 2infiltration of plasma cells containing Russell bodies (mott cells), and 3granuloma 
formation; 4the number of granulomatous lesions per lung; 5average area of each granuloma; 4, 5values are the mean ± standard deviation
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(Supplementary Figure 1K, Table 2) and 100% of 
mice treated with 3.0 mg of the particles (Supple-
mentary Figure 1L, Table 2). In addition, lymphoid 
hyperplasia of bronchus-associated lymphoid tissue 
(BALT) with aggregation of macrophages containing 
fine particles and mott cells was observed at 4 months 
after instillation in both high and low dose treated 
groups (Supplementary Figure 4A–C).
Histopathology of the tracheobronchial  
lymph nodes
Histological sections of the tracheobronchial lymph 
nodes from control animals instilled with normal 
saline showed no significant changes at all time ex-
amined after treatment.
At 24 hours and 1 week after instillation, mild infiltra-
tion of neutrophils in the tracheobronchial lymph nodes 
was observed in all treated groups. At 1 month after 
instillation, macrophages containing fine particles were 
present in the marginal sinus of the tracheobronchial 
lymph nodes in the 3.0 mg treated group. At 2 months 
after instillation, macrophages containing fine particles 
were frequently observed in the entire area of the tra-
cheobronchial lymph nodes in the 3.0 mg treated group. 
At 3 and 4 months after instillation, focal aggregations 
of macrophages containing fine particles were seen in 
the tracheobronchial lymph nodes in the 3.0 mg treated 
group. In the 0.4 mg treated group, macrophages that 
contained particles were present in the tracheobronchial 
lymph nodes at 4 months after instillation.
Immunohistochemical examination of the lungs
The results of the immunohistochemical examination 
of the lungs of mice exposed to ASD are presented in 
Table 3 and Figures 1–4.
a-SMA
Spindle-shaped to elongated cells in the inflammatory 
foci at 1 week and 4 months after 3.0 mg of ASD in-
stillation showed positive immunolabeling for a-SMA 
(Supplementary Figure 3C). Positive immunolabeling 
was not observed in inflammatory foci at the other 
time points examined.
Collagen III
Fibrillar component in the interstitium of the granu-
lomatous lesions at 4 months after treatment with 
3.0 mg ASD showed positive immunolabeling for 
collagen III (Supplementary Figure 3D). 
MMP-9
The cytoplasm of macrophages in inflammatory le-
sions showed positive immunolabeling for MMP-9 
at 24 hours (Figure 1A), 1 (Figure 1C) and 2 months 
(Figure 1D) after instillation of 3.0 mg of ASD. 
However, at 1 week (Figure 1B), 3 (Figure 1E) and 
4 months (Figure 1F) after instillation of 3.0 mg of 
ASD, no positive staining for MMP-9 was observed 
in the granulomatous lesions.
TIMP-1
The cytoplasm of macrophages showed positive 
immunolabeling for TIMP-1 at 2 (Figure 2D) and 
4 months (Figure 2F) after 3.0 mg of ASD instillation. 
Positive immunolabeling was not observed in the 
inflammatory foci of the other time points examined 
(Figure 2A–C, E).
CD3 and CD20
At 2 months after treatment with 3.0 mg of ASD 
and at 3 months after treatment with 0.4 mg of ASD, 
Table 3. Summary of the immunohistochemical findings in lungs of mice treated with 3.0 mg of Asian sand dust particles
Localization Time after ASD instillation
24 hours 1 week 1 month 2 months 3 months 4 months
MMP-9 Macrophages + – + ++ ± ±
TIMP-1 Macrophages – – – + – ++
Collagen III Interstitium NE NE NE NE NE +
a-SMA Spindle-shaped cells – + – – – +
Immunoglobulin G Lymphocytes NE NE NE NE NE ++
CD3 T-lymphocytes NE NE NE +++ NE +++
CD20 B-lymphocytes NE NE NE + NE ++
IL-1b Macrophages + – + + + +
iNOS Macrophages + + – +++ + +
Abbreviations: a-SMA — alpha-smooth muscle actin; ASD — Asian sand dust; IL-1b — interleukin-1b; MMP-9 — matrix metalloproteinase-9; 
TIMP-1 — tissue inhibitor of metalloproteinases-1; iNOS — inducible nitric oxide synthase; NE — not examined
299Kosa induces granulomatous lesions in mouse lung
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0030
www.fhc.viamedica.pl
many lymphocytes observed around blood vessels 
and bronchioles showed positive immunolabeling 
for CD3 (Supplementary Figure 2C). Some scattered 
lymphocytes in the same lesions showed positive im-
munolabeling for CD20 (Supplementary Figure 2D). 
Immunoglobulin G
The cytoplasm of lymphocytes, accumulated 
around bronchioles at 4 months after treatment 
with 3.0 mg of ASD, showed positive immuno-
labeling for immunoglobulin G (Supplementary 
Figure 4D).
Interleukin-1b (IL-1b)
The cytoplasm of macrophages in the inflammatory 
lesions at 24 hours after instillation of 3.0 mg of ASD 
showed positive immunolabeling for IL-1b (Figure 3A). 
Inflammatory lesions were negative for IL-1b at 
Figure 1. Matrix metalloproteinase (MMP)-9 immunohistochemistry in the lungs of mice treated with 3.0 mg of Asian 
sand dust at 24 hours (A), 1 week (B), 1 month (C), 2 months (D), 3 months (E) and 4 months (F) after instillation.  
A. Macrophages (arrows) in the inflammatory lesions show positive immunolabelings for MMP-9; B, E, F. Inflammatory 
lesions show negative immunolabeling for MMP-9; C, D. Scattered alveolar macrophages (arrows) show positive immuno-
labelings for MMP-9. Bars = 20 μm
A B
C D
E F
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1 week after treatment with 3.0 mg of ASD (Figure 3B). 
At 1 (Figure 3C), 2 (Figure 3D), 3 (Figure 3E) and 
4 months (Figure 3F) after treatment with 3.0 mg 
of ASD, macrophages showed positive immunolabe-
ling for IL-1b.
iNOS
The cytoplasm of macrophages in inflammatory foci 
at 24 hours (Figure 4A) and 1 week (Figure 4B) after 
instillation of 3.0 mg of ASD showed positive immu-
nolabeling for iNOS. Inflammatory lesions at 1 month 
(Figure 4C) after treatment with 3.0 mg of ASD were 
negative for iNOS. At 2 months after instillation of 
3.0 mg of ASD, many macrophages in the inflamma-
tory lesion showed strong positive immunolabeling for 
iNOS (Figure 4D). At 3 and 4 months after instillation, 
macrophages in granulomatous lesions (Figure 4E, F) 
showed positive immunolabeling for iNOS.
Figure 2. Immunoreactivity of tissue inhibitor of metalloproteinases (TIMP)-1 in lungs of mice treated with 3.0 mg of 
Asian sand dust at 24 hours (A), 1 week (B), 1 month (C), 2 months (D), 3 months (E) and 4 months (F) after instillation. 
A–C, E. Inflammatory lesions show negative immunolabelings for TIMP-1; D. Large foamy macrophages (arrows) show 
moderately positive immunolabeling for TIMP-1; F. Alveolar macrophages (arrows) in the granulomatous lesions show 
strong positive immunolabelings for TIMP-1. Bars = 20 μm
A B
C D
E F
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Discussion
Chronic pulmonary toxicity induced by intratracheal 
instillation of the mineral component of low doses 
(0.2, 0.4 mg) of ASD particles or a high dose (3.0 mg) 
of ASD particles, free from chemical and biological 
substances, was pathologically examined in this study. 
Both acute (examined at 24 hours and 1 week) or 
chronic (3 months and 4 months) pulmonary inflam-
matory changes in lungs exposed to low doses of ASD 
were evaluated. ASD caused acute inflammatory 
changes in the lung 24 hours after instillation. The 
changes were transient and subsided at 1 week fol-
lowing treatment. After this period, the lung lesions 
seemed to diminish; only minor foci were occasionally 
observed at 1 and 2 months after instillation. Exacer-
bation of inflammation, which is characterized by the 
infiltration of lymphocytes, was, however, occasionally 
Figure 3. Interleukin (IL)-1b immunoreactivity in lungs of mice treated with 3.0 mg of Asian sand dust at 24 hours (A), 
1 week (B), 1 month (C), 2 months (D), 3 months (E) and 4 months (F) after instillation. A, C, D. Alveolar macrophages 
(arrows) in the inflammatory lesions show positive immunolabelings for IL-1b; B. Inflammatory lesions show negative 
immunolabelings for IL-1b; E, F. Macrophages (arrows) in the granulomatous lesions show positive immunolabelings  
for IL-1b. Bars = 20 μm
A B
C D
E F
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observed at 3 and 4 months. Multinucleated giant 
cells were also reported in the lung lesions at 2, 3, 
and 4 months following treatment. Small granuloma 
formation was observed in the lung lesions and scat-
tered macrophages containing ASD particles were 
observed in the tracheobronchial lymph nodes at 
4 months. These findings, including granuloma for-
mation observed at low doses (0.4 mg), were qualita-
tively similar to those reported in previous high dose 
(3.0 mg) experiments [29]. 
In the aforementioned previous study [29], in-
flammatory responses to high doses of ASD were 
examined for up to 3 months after instillation; granu-
lomatous lesions were observed at 2 and 3 months 
following treatment. In the present study, pathological 
examination during the longer period (4 months) 
was carried out in order to further elucidate the 
pathomorphogenesis of granulomatous lesions. The 
size of granulomatous lesions in mice treated with 
3.0 mg ASD gradually increased in the period from 
Figure 4. Inducible nitric oxide synthase (iNOS) immunoreactivity in lungs of mice treated with 3.0 mg of Asian sand dust 
at 24 hours (A), 1 week (B), 1 month (C), 2 months (D), 3 months (E) and 4 months (F) after instillation. A, B, D. Macro-
phages (arrows) in the inflammatory lesions show positive immunolabelings for iNOS; C. Inflammatory lesions show 
negative immunolabelings for iNOS; E, F. Macrophages (arrows) in the granulomatous lesions show positive immunola-
belings for iNOS. Bars = 20 μm
A B
C D
E F
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2 to 4 months after instillation. These lesions were 
composed of inflammatory cells such as macrophages 
and lymphocytes at 2 months, and inflammatory cells 
including macrophages and spindle-shaped cells at 
4 months along with an increase in the interstitium. 
The interstitial substance was positive for collagen III 
by immunohistochemistry, suggesting that the fibrotic 
event is associated with the development and enlarge-
ment of granulomatous lesions after instillation of 
ASD particles. 
Previous research [15] reported that the major 
mineralogical component of ASD is silica (SiO2), 
which is derived mainly from feldspar and quartz 
(crystalline silica). Occupational exposure to crystal-
line silica leads to silicosis, which is characterized by 
a progressive granulomatous and fibrogenic response 
in the lung [21]. In experimental silicosis, the increase 
of collagen deposition in the lungs of rats over time 
has been reported [32]. Therefore, it is expected that 
the fibrotic response may progress and the size of 
granulomatous lesions become larger when observed 
at more advanced time points after instillation of 
a high dose of ASD.
The volume of the pulmonary extracellular matrix 
is, in part, regulated by matrix metalloproteinases 
(MMPs) and tissue inhibitor of metalloproteinases 
(TIMPs). MMPs play a central role in the regulation 
of multiple cellular functions such as cell prolifera-
tion, adhesion, migration, differentiation, angiogen-
esis, and apoptosis [33] and are capable of digesting 
extracellular matrix such as collagen and basement 
membrane components [34] and also acting as cell 
mediators. Because of its strong destructive ability, the 
activity of MMPs is strictly regulated by TIMPs [35]. 
TIMPs are also able to promote the proliferation of 
a variety of cells including fibroblasts [36]. Several pul-
monary chronic diseases are proposed to result from 
the disturbance of the equilibrium between the syn-
thesis and degradation of the pulmonary extracellular 
matrix; the activation of MMPs and TIMPs is involved 
in the process. Previous research has reported that 
the excessive or inappropriate expression of MMPs 
contributes to the pathogenesis of tissue destructive 
diseases such as pulmonary emphysema [37]. On the 
other hand, the development of pulmonary fibrosis is 
associated with an increase of TIMP-1 expression [38]. 
In addition, this increased expression of TIMP-1 
appears to precede the increased accumulation of 
collagen [38]. The study reported here demonstrated 
the expression of MMP-9 in the acute inflammatory 
period and TIMP-1 in the chronic inflammatory 
period. Previously, the disruption of the basement 
membrane was observed in the lungs of mice treated 
with a high dose of ASD particles at 24 hours after 
instillation [28]. Expression of MMP-9 in the acute 
inflammatory lesions reported in this study may play 
a part in basement membrane disruption. Imbalance 
between MMP-9 and TIMP-1 was demonstrated in 
the lesions of acute pancreatitis [39]. As shown in 
experimental silicosis [40, 41], increased TIMP-1 
expression, decreased MMP-9 expression and depo-
sition of collagen in the lesions were also observed at 
the chronic period in this study. These findings suggest 
the possible association of the imbalance of expression 
between MMP and TIMP with the development of 
granulomatous lesions in the lungs of mice treated 
with ASD. 
The role of cytokines and oxidative stress markers, 
IL-1b and inducible iNOS, respectively, has been re-
ported in studies investigating the pathogenesis of pul-
monary toxicity induced by crystalline silica [42, 43]. 
Mice genetically deficient (knockout) in IL-1b or iNOS 
showed significantly reduced silicotic lesions [44]. 
The generation of IL-1b [43] and nitric oxide [44] 
was associated with the development of lung lesions 
including granuloma formation and fibrosis in exper-
imental silicosis. In this study of ASD toxicity, IL-1b 
and iNOS expression were also demonstrated in both 
acute and chronic inflammatory lesions, suggesting 
that secondary released cytokines and oxidative stress 
generated in lesions may be involved in the develop-
ment of the acute and chronic lung lesions induced 
by the intratracheally instilled ASD particles [45].
Silicosis is characterized in part by elevations in se-
rum and bronchoalveolar lavage immunoglobulins in 
silicosis patients [46, 47] and experimentally exposed 
animals [20]. Another well-known health outcome 
associated with silica exposure is an increase in the 
incidence of autoimmune disorders [48, 49] including 
rheumatoid arthritis [50], scleroderma [51], system-
ic lupus erythematosus [52], and antineutrophilic 
cytoplasmic antibody-related nephritis [53]. Recent 
epidemiological studies on ASD have proposed that 
increased exposure to ASD particles is associated 
with the increased susceptibility to asthma, allergic 
rhinitis, contact dermatitis and conjunctivitis [1, 10, 
54–57]. The previous study of ASD instillation in 
mice [28] demonstrated lymphocytic infiltration, which is 
characterized by a mixed population of many T lym-
phocytes and some B lymphocytes, at 2 months after 
instillation of ASD particles. In this current study, 
many plasma cells containing Russell bodies (called 
mott cells) and the accumulation of immunoglobulin 
G-positive cells were observed at the peribronchial 
lesions of 0.4 and 3.0 mg treated mice at 4 months 
after instillation. In general, mott cells are regarded 
as plasma cells undergoing excessive synthesis of im-
munoglobulin and defective in secretion [31]. Mott 
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cells are rare in normal tissue but frequently encoun-
tered in lymphoid tissues of murine and human au-
toimmune diseases [58] and in chronic inflammatory 
lesions with hyper-activation of the immune system 
by pathogens [59]. Thus, the presence of plasma 
cells containing Russell bodies observed in the ASD 
treated mice in this study suggests that the activation 
of antibody-mediated immunity occurred in addition 
to cell-mediated immunity, which could be in a state 
of hyper-immunization.
Conclusions
This study demonstrated that the low (0.4 mg) and 
high (3.0 mg) dose of mineralogical components of 
ASD particles, free from chemical and biological 
pollutants, induced granulomatous lesions in lung 
tissues at 2 months after intratracheal instillation. 
The dose (0.4 mg) used in this study is similar to the 
volume of ASD particles that could have been inhaled 
on the seven consecutive days of the recorded highest 
concentration of suspended particulate matter (SPM, 
0.898 mg/m3) in ASD season in Japan. In addition, the 
size of the granulomatous lesions induced by the in-
tratracheal instillation of a high (3.0 mg) dose of ASD 
gradually increased with collagen deposition over 
time. These findings suggest that ASD exposure has 
implications for public health. Since this study used 
the intratracheal instillation of ASD particles, with 
which is different from the atmospheric exposure of 
ASD in the natural environment, more experimental 
studies using the inhalation method with lower doses 
of ASD to mimic the natural low-level exposure 
occurring during the Kosa event season should be 
conducted in the future.
Acknowledgements
This work was supported in part by JSPS KAKENHI 
Grant Number 24580425, a Special Project (Assess-
ment and Control of Dust Emission in Degraded 
Drylands of East Asia), MEXT, Japan for the re-
search, authorship, and/or publication of this article, 
and by a research project grant awarded by the Azabu 
University.
References
1. Yang CY, Tsai SS, Chang CC, Ho SC. Effects of Asian dust 
storm events on daily admissions for asthma in Taipei, Taiwan. 
Inhal Toxicol. 2005;17:817–821. PMID: 16282159.
2. Bell ML, Levy JK, Lin Z. The effect of sandstorms and air 
pollution on cause-specific hospital admissions in Taipei, 
Taiwan. Occup Environ Med. 2008;65:104–111. doi: 10.1136/
oem.2006.031500.
3. Chan CC, Chuang KJ, Chen WJ, Chang WT, Lee CT, Peng CM. 
Increasing cardiopulmonary emergency visits by long- range 
transported Asian dust storms in Taiwan. Environ Res. 
2008;106:393–400. PMID: 17959168.
4. Cheng, MF, Ho SC, Chiu HF, Wu TN, Chen PS, Yang CY. 
Consequences of exposure to Asian dust storm events 
on daily pneumonia hospital admissions in Taipei, Tai-
wan. J Toxicol Environ Health A. 2008;71:1295–1299. doi: 
10.1080/15287390802114808.
5. Chiu HF, Tiao MM, Ho SC, Kuo HW, Wu TN, Yang CY. 
Effects of Asian dust storm events on hospital admissions for 
chronic obstructive pulmonary disease in Taipei, Taiwan. Inhal 
Toxicol. 2008;20:777–781. doi: 10.1080/08958370802005308.
6. Lai LW, Cheng WL. The impact of air quality on respiratory 
admissions during Asian dust storm periods. Int J Environ He-
alth Res. 2008;18:429–450. doi: 10.1080/09603120802272227.
7. Kang JH, Liu TC, Keller J, Lin HC. Asian dust storm events 
are associated with an acute increase in stroke hospitalisation. 
J Epidemiol Community Health. 2013;67:125–131. doi: 10.1136/
jech-2011-200794.
8. Yang CY, Cheng MH, Chen CC. Effects of Asian dust storm 
events on hospital admissions for congestive heart failure in 
Taipei, Taiwan. J Toxicol Environ Health A. 2009;72:324–328. 
doi: 10.1080/15287390802529880.
9. Hwang SS, Cho SH, Kwon HJ. Effects of the severe Asian 
dust events on daily mortality during the spring of 2002, in 
Seoul, Korea. J Prev Med Public Health. 2005;38:197–202. 
PMID: 16315758.
10. Kwon H, Cho S, Chun Y, Lagarde F, Pershagen G. Effects 
of the Asian dust events on daily mortality in Seoul, Korea. 
Environ Res. 2002;90:1–5. PMID: 12359184.
11. Lee H, Kim H, Honda Y, Lim YH, Yi S. Effect of Asian 
dust storms on daily mortality in seven metropolitan cities 
of Korea. Atmos Environ. 2013;79:510–517. doi: 10.1016/j.
atmosenv.2013.06.046.
12. Lee JT, Son JY, Cho YS. A comparison of mortality related to 
urban air particles between periods with Asian dust days and 
without Asian dust days in Seoul, Korea, 2000–2004. Environ 
Res. 2007;105:409–413. PMID: 17659273.
13. Chen YS, Sheen PC, Chen ER, Liu YK, Wu TN, Yang CY. 
Effects of Asian dust storm events on daily mortality in Taipei, 
Taiwan. Environ Res. 2004;95:151–155. PMID: 15147920.
14. Mori I, Nishikawa M, Tanimura T, Quan H. Change in size 
distribution and chemical composition of kosa (Asian dust) 
aerosol during long-range transport. Atmospheric Environment. 
2003;37:4253–4263. doi: 10.1016/S1352-2310(03)00535-1.
15. Nishikawa M, Quan H, Morita M. Preparation and evaluation 
of certified reference materials for Asian mineral dust. Global 
Environ Res. 2000;1:103–113.
16. Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson 
WT. Occupational silica exposure and risk of various dise-
ases: an analysis using death certificates from 27 states of 
the United States. Occup Environ Med. 2003;60:122–129. 
PMID: 12554840.
17. Kumagai N, Nishimura Y, Maeda M, Hayashi H, Otsuki T. 
Immunological effects of silica/asbestos. Nihon Eiseigaku 
Zasshi. 2010;65:493–499. PMID: 20885075.
18. Wu P, Miura Y, Hyodoh F et al. Reduced function of 
CD4+25+ regulatory T cell fraction in silicosis patients. 
Int J Immunopathol Pharmacol. 2006;19:357–368. PMID: 
16831302.
19. Green FH, Vallyathan V, Hahn FF. Comparative pathology 
of environmental lung disease: an overview. Toxicol Pathol. 
2007;35:136–147. PMID: 17325982.
20. Huang SH, Hubbs AF, Stanley CF et al. Immunoglobulin re-
sponses to experimental silicosis. Toxicol Sci. 2001;59:108–117. 
PMID: 11134550.
305Kosa induces granulomatous lesions in mouse lung
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0030
www.fhc.viamedica.pl
21. Ishihara Y, Yasuhara T, Ishiyama S, Kawashima H, Miyasa-
ka M, Miyazaki T. The role of leukocytes during acute phase 
inflammation in crystalline silica-induced lung injury. Exp 
Lung Res. 2001;27:589–603. PMID: 11597119.
22. Langley RJ, Kalra R, Mishra NC et al. A biphasic response 
to silica: I. Immunostimulation is restricted to the early 
stage of silicosis in lewis rats. Am J Respir Cell Mol Biol. 
2004;30:823–829. PMID: 14742293.
23. Langley RJ, Mishra NC, Peña-Philippides JC, Hutt JA, Sopo- 
ri ML. Granuloma formation induced by low-dose chronic 
silica inhalation is associated with an anti-apoptotic response 
in Lewis rats. J Toxicol Environ Health A. 2010;73:669–683. 
doi: 10.1080/15287390903578521.
24. Porter DW, Hubbs AF, Mercer R et al. Progression of lung 
inflammation and damage in rats after cessation of silica 
inhalation. Toxicol Sci. 2004;79:370–380. PMID: 15056817.
25. Friedetzky A, Garn H, Kirchner A, Gemsa D. Histopathologi-
cal changes in enlarged thoracic lymph nodes during the deve-
lopment of silicosis in rats. Immunobiology. 1998;199:119–132. 
PMID: 9717672.
26. Porter DW, Millecchia L, Robinson VA et al. Enhanced nitric 
oxide and reactive oxygen species production and damage 
after inhalation of silica. Am J Physiol Lung Cell Mol Physiol. 
2002;283:L485–L493. PMID: 12114212.
27. Ichinose T, Nishikawa M, Takano H et al. Pulmonary toxicity 
induced by intratracheal instillation of Asian yellow dust 
(Kosa) in mice. Environ Toxicol Pharmacol. 2005;20:48–56. 
doi: 10.1016/j.etap.2004.10.009.
28. Naota M, Mukaiyama T, Shimada A et al. Pathological study 
of acute pulmonary toxicity induced by intratracheally instilled 
Asian sand dust (kosa). Toxicol Pathol. 2010;38:1099–1110. 
doi: 10.1177/0192623310385143.
29. Naota M, Shiotsu S, Shimada A et al. Pathological Study of 
Chronic Pulmonary Toxicity Induced by Intratracheally Instil-
led Asian Sand Dust (Kosa). Toxicol Pathol. 2013;41:48–62. 
doi: 10.1177/0192623312452490.
30. Iwatsuki M, Kyotani T, Katsubar K. Fractional determination 
of elemental carbon and total soluble and insoluble organic 
compounds in airborne particulate matter by thermal analysis 
combined with extraction and heavy liquid separation. Bunseki 
Kagaku. 1998;43:879–884. doi: 10.2116/analsci.14.321.
31. Bavle RM. Bizzare plasma cell — mott cell. J Oral Maxillofac 
Pathol. 2013;17:2–3. doi: 10.4103/0973-029X.110682.
32. Reiser KM, Haschek WM, Hesterberg TW, Last JA. Experi-
mental silicosis. II. Long-term effects of intratracheally instilled 
quartz on collagen metabolism and morphologic characteristics 
of rat lungs. Am J Pathol. 1983;110:30–40. PMID: 6295174.
33. Pardo A, Selman M. Matrix metalloproteases in aberrant 
fibrotic tissue remodeling. Proc Am Thorac Soc. 2006;3:383–
–388. PMID: 16738205.
34. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloprote-
inases and the regulation of tissue remodelling. Nat Rev Mol 
Cell Biol. 2007;8:221–233. PMID: 17318226.
35. Li C, Kuemmerle JF. Mechanisms that mediate the de-
velopment of fibrosis in patients with Crohn’s disease. 
Inflamm Bowel Dis. 2014;20:1250–1258. doi: 10.1097/
MIB.0000000000000043.
36. Nishimura K, Yamashita K, Kato Y et al. Inhibitory activity on 
matrix metalloproteinases and cell-proliferating activity of tissue 
inhibitor of metalloproteinases-1 (TIMP-1)-contrastive diffe-
rence between human and bovine TIMP-1s on mouse cell pro-
liferation. Growth Factors. 2005;23:135–142. PMID: 16019435.
37. Churg A, Zhou S, Wright JL. Series “matrix metallopro-
teinases in lung health and disease”: Matrix metallopro-
teinases in COPD. Eur Respir J. 2012;39:197–209. doi: 
10.1183/09031936.00121611.
38. Ruiz V, Ordóñez RM, Berumen J et al. Unbalanced col-
lagenases/TIMP-1 expression and epithelial apoptosis in 
experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 
2003;285:L1026–L1036. PMID: 12882763.
39. Wereszczynska-Siemiatkowska U, Siemiatkowski A, Swidnic-
ka-Siergiejko A, Mroczko B, Dabrowski A. The imbalance 
between matrix metalloproteinase 9 and tissue inhibitor of 
metalloproteinase 1 in acute pancreatitis. Z Gastroenterol. 
2015;53:199–204. doi: 10.1055/s-0034-1385705.
40. Pardo A, Pérez-Ramos J, Segura-Valdez L, Ramírez R, 
Selman M. Expression and localization of TIMP-1, TIMP-2, 
MMP-13, MMP-2, and MMP-9 in early and advanced expe-
rimental lung silicosis. Ann NY Acad Sci. 1999;878:587–589. 
PMID: 10415781.
41. Pérez-Ramos J, Segura-Valdez ML, Vanda B, Selman M, 
Pardo A. Matrix metalloproteinases 2, 9, and 13, and tissue 
inhibitors of metalloproteinases 1 and 2 in experimental lung 
silicosis. Am J Respir Crit Care Med. 1999;160:1274–1282. 
PMID: 10508819.
42. Castranova V, Porter D, Millecchia L, Ma J, Hubbs A, Teass A. 
Effect of inhaled crystalline silica in a rat model: time course 
of pulmonary reactions. Mol Cell Biochem. 2002; 234/235:177–
–184. PMID: 12162431.
43. Guo J, Gu N, Chen J et al. Neutralization of interleukin-1 
beta attenuates silica-induced lung inflammation and fibro-
sis in C57BL/6 mice. Arch Toxicol. 2013;87:1963–1973. doi: 
10.1007/s00204-013-1063-z.
44. Srivastava KD, Rom WN, Jagirdar J, Yie TA, Gordon T, 
Tchou-Wong KM. Crucial role of interleukin-1beta and nitric 
oxide synthase in silica-induced inflammation and apoptosis 
in mice. Am J Respir Crit Care Med. 2002;165:527–533. PMID: 
11850347.
45. Yeo NK, Hwang YJ, Kim ST, Kwon HJ, Jang YJ. Asian sand 
dust enhances rhinovirus-induced cytokine secretion and 
viral replication in human nasal epithelial cells. Inhal Toxicol. 
2010;22:1038–1045. doi: 10.3109/08958378.2010.516282.
46. Beshir S, Shaheen WA, Elserougy S, Aziz HM. Serum auto-
antibodies in silicosis and non-silicosis cement workers. Am 
J Ind Med. 2015;58:238–244. doi: 10.1002/ajim.22413.
47. Yao SQ, He QC, Yuan JX et al. Role of Fas/FasL pathway- 
-mediated alveolar macrophages releasing inflammatory cyto-
kines in human silicosis. Biomed Environ Sci. 2013;26:930–933. 
doi: 10.3967/bes2013.024.
48. Maeda M, Nishimura Y, Kumagai N et al. Dysregulation of 
the immune system caused by silica and asbestos. J Immuno-
toxicol. 2010;7:268–278. doi: 10.3109/1547691X.2010.512579.
49. Parks CG, Conrad K, Cooper GS. Occupational exposure 
to crystalline silica and autoimmune disease. Environ Health 
Perspect. 1999;107(Suppl. 5):793–802. PMID: 10970168.
50. Cooper GS. Occupational exposures and risk of rheumatoid 
arthritis: continued advances and opportunities for research. 
J Rheumatol. 2008;35:950–952. PMID: 18528947.
51. Martin JR, Griffin M, Moore E et al. Systemic sclerosis 
(scleroderma) in two iron ore mines. Occup Med (Lond). 
1999;49:161–169. PMID: 10451597.
52. Parks CG, Cooper GS. Occupational exposures and risk of 
systemic lupus erythematosus: a review of the evidence and 
exposure assessment methods in population- and clinic-based 
studies. Lupus. 2006;15:728–736. PMID: 17153843.
53. Tervaert JW, Stegeman CA, Kallenberg CG. Silicon exposure 
and vasculitis. Curr Opin Rheumatol. 1998;10:12–17. PMID: 
9448985.
306 Akinori Shimada et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0030
www.fhc.viamedica.pl
54. Chen YS, Yang CY. Effects of Asian dust storm events on 
daily hospital admissions for cardiovascular disease in Taipei, 
Taiwan. J Toxicol Environ Health A. 2005;68:1457–1464. 
PMID: 16076758.
55. Im HJ, Kwon HJ, Ha M et al. Public perceptions of the risk 
of Asian dust storms in Seoul and its metropolitan area. 
J Prev Med Public Health. 2006;39:205–212. PMID: 16764494.
56. Kanatani KT, Ito I, Al-Delaimy WK et al. Desert dust exposu-
re is associated with increased risk of asthma hospitalization 
in children. Am J Respir Crit Care Med. 2010;182:1475–1481. 
doi: 10.1164/rccm.201002-0296OC.
57. Yang CY. Effects of Asian dust storm events on daily clinical 
visits for conjunctivitis in Taipei, Taiwan. J Toxicol Environ 
Health A. 2006;69:1673–1680. PMID: 16864418.
58. Honjo K, Kubagawa Y, Suzuki Y et al. Enhanced auto-anti-
body production and Mott cell formation in FcμR-deficient 
autoimmune mice. Int Immunol. 2014;26:659–672. doi: 
10.1093/intimm/dxu070.
59. Ensari A, Savas B, Okcu Heper A, Kuzu I, Idilman R. An 
unusual presentation of Helicobacter pylori infection: so-cal-
led “Russell body gastritis”. Virchows Arch. 2005;446:463–466. 
PMID: 15744498.
Submitted: 17 April, 2015 
Accepted after reviews: 13 November, 2015 
Available as AoP: 19 November, 2015
